Please try another search
Emmessar Biotech & Nutrition Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 10.19 million compared to INR 3.65 million a year ago. Revenue was INR 27.7 million compared to INR 22.84 million a year ago. Net income was INR 5.04 million compared to INR 4.75 million a year ago. Basic earnings per share from continuing operations was INR 0.99 compared to INR 0.94 a year ago. Diluted earnings per share from continuing operations was INR 0.99 compared to INR 0.94 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Revenue | 8.53 | 6.12 | 5.25 | 4.94 |
Gross Profit | 7.13 | 5.88 | 5.09 | 3.24 |
Operating Income | 2.94 | 2.88 | 1.59 | 0.112 |
Net Income | 1.29 | 1.97 | 0.549 | 1.96 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Total Assets | 82.82 | 79.43 | ||
Total Liabilities | 13.66 | 12.78 | ||
Total Equity | 69.17 | 66.65 | 66.65 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | ||||
Cash From Investing Activities | ||||
Cash From Financing Activities | ||||
Net Change in Cash |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review